Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Equipment & Supplies
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:SMA
- CUSIP: 87154620
- Web: N/A
- 50 Day Moving Avg: $434.00
- 200 Day Moving Avg: $385.00
- Trailing P/E Ratio: N/A
- P/E Growth: 0
Frequently Asked Questions for Symmetry Medical (NYSE:SMA)
What is Symmetry Medical's stock symbol?
Symmetry Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SMA."
How were Symmetry Medical's earnings last quarter?
Symmetry Medical Inc. (NYSE:SMA) issued its quarterly earnings results on Thursday, October, 30th. The company reported $0.13 EPS for the quarter, missing the Zacks' consensus estimate of $0.15 by $0.02. The company earned $95.90 million during the quarter, compared to analyst estimates of $98.24 million. The company's revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.08 EPS. View Symmetry Medical's Earnings History.
Who are some of Symmetry Medical's key competitors?
Some companies that are related to Symmetry Medical include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), 3SBio (SSRX), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT) and Allos Therapeutics (ALTH).
How do I buy Symmetry Medical stock?
Shares of Symmetry Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Symmetry Medical stock cost?
One share of Symmetry Medical stock can currently be purchased for approximately $1.50.
Consensus Ratings for Symmetry Medical (NYSE:SMA) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Symmetry Medical (NYSE:SMA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Symmetry Medical (NYSE:SMA)Earnings History by Quarter for Symmetry Medical (NYSE:SMA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/30/2014||Q3||$0.15||$0.13||$98.24 million||$95.90 million||View||Listen|
|8/4/2014||Q2||$0.12||$0.17||$98.38 million||$101.30 million||View||Listen|
|5/1/2014||Q1||$0.09||$0.09||$99.10 million||$101.30 million||View||Listen|
|2/20/2014||Q413||$0.08||$0.10||$101.50 million||$101.20 million||View||Listen|
|10/31/2013||Q313||$0.07||$0.08||$99.05 million||$98.00 million||View||Listen|
|8/1/2013||Q2 2013||$0.08||$0.09||$99.01 million||$101.90 million||View||Listen|
|5/2/2013||Q1 2013||$0.15||$0.06||$106.04 million||$98.90 million||View||Listen|
|2/21/2013||Q4 2012||$0.18||$0.17||$107.81 million||$106.60 million||View||Listen|
|11/1/2012||Q312||$0.15||$0.18||$104.33 million||$100.90 million||View||N/A|
Earnings Estimates for Symmetry Medical (NYSE:SMA)
Current Year EPS Consensus Estimate: $-0.01 EPS
Dividend History for Symmetry Medical (NYSE:SMA)
No dividend announcements for this company have been tracked by MarketBeat.com
Headline Trends for Symmetry Medical (NYSE:SMA)
Latest Headlines for Symmetry Medical (NYSE:SMA)
Symmetry Medical (SMA) Chart for Sunday, May, 28, 2017